The Ayushman Bharat program successfully delivers hospital care, but it falters when tackling the high costs associated with medications for chronic and rare conditions. Patients frequently have to pay out of pocket for these essential drugs.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/nUkz5Dv
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» 'Opaque pricing cripples Ayushman drug coverage'






0 comments:
Post a Comment